Maternal Mental Health Market Report Scope & Overview:

The Maternal Mental Health Market was valued at USD 14.79 Billion in 2025 and is expected to reach USD 134.97 Billion by 2035, growing at a CAGR of 24.75% from 2026 to 2035.

Maternal mental health means the emotional, psychological, and social well-being of a mother during pregnancy, delivery, and post-delivery period which covers various maternal mental health disorders like postpartum depression, anxiety, and other mood disorders that may affect both the mother and child. About forty percent of women face signs of maternal mental disorders following childbirth, resulting in the need for effective management of mental well-being, whereas good management, diagnosis, and treatment is necessary for securing the mother's well-being and creating a healthy parent-child bond. Market growth has been consistent over the years owing to increased investment by the government aimed at reducing maternal mortality cases, high occurrences of postpartum depression, rising awareness about mental wellness in pregnant women, and innovations in the use of artificial intelligence in diagnosing mental illness among expectant mothers.

The acquisition of Naytal by Maven Clinic took place in March 2025 as part of Maven Clinic's approach to fast-track their growth in the UK and Europe region as a means of improving Maven Clinic’s ability to offer mental health services to their increasing number of clients.

Market Size and Forecast

• Market Size in 2026E: USD 18.45 Billion
• Market Size by 2035: USD 134.97 Billion
• CAGR: 24.75% from 2026 to 2035
• Fastest Growing Region: Asia Pacific
• Largest Region: North America

To Get more information Maternal Mental Health Market - Request Free Sample Report

Maternal Mental Health Market Trends

• Significant progress is being made by artificial intelligence in identifying perinatal mental health conditions, including anxiety and postpartum depression.
• The U.S. FDA approved zuranolone in 2023, the first oral drug for postpartum depression offering a fast-acting, outpatient solution.
• Growing incorporation of technology in healthcare services continues resulting in significant commercial advances across the sector.
• International research funding continues supporting innovative approaches, including music-based interventions for perinatal mental health.
• Government health agencies continue announcing increased funding, policy action, and reports strengthening maternal health programs.

The United States Maternal Mental Health Market Outlook

The United States Maternal Mental Health Market was valued at USD 5.10 Billion in 2025 and is expected to reach USD 68.80 Billion by 2035, growing at a CAGR of 29.71% from 2026 to 2035.

By 2025, the US had become the dominant actor in the North American area as a result of good government investment, increasing research, and the existence of important actors within the sector. In January 2025, the Health Resources and Services Administration marked a milestone year of developments in the motherhood project as it provided additional nine million dollars for the Enhancing Maternal Health Initiative project.

LunaJoy Health has been able to raise 4.2 million dollars in investment money in January 2025, helping the company to solidify its position as a digital maternal mental health company for American mothers who are in need of psychiatric help.

Maternal Mental Health Market Segment Analysis

• By Disease Indication, the pregnancy and postpartum general anxiety segment held approximately 34.80% share in 2025, while the postpartum depression segment is the fastest growing.
• By Treatment, the interpersonal psychotherapy segment held approximately 40.00% share in 2025, while the same segment is also the fastest growing.
• By End-User, the hospitals and clinics segment held the largest share in 2025, while the telehealth digital platforms segment is the fastest growing.

By Disease Indication, pregnancy and postpartum general anxiety segment dominates the market, postpartum depression grows fastest

The pregnancy and postpartum general anxiety segment held approximately 34.80% of total market revenue in 2025, reflecting the substantial prevalence of anxiety symptoms that continue affecting a significant share of pregnant women and new mothers. That substantial, sustained patient population continues to keep this disease indication firmly at the top of the broader disease indication segmentation, with postpartum depression, dysthymia, and psychosis continuing to represent substantial additional indication categories.

The postpartum depression segment is projected to grow at the fastest rate during the forecast period, propelled by rising incidences of postpartum depression and significant pharmaceutical innovation including the FDA approval of zuranolone, the first oral drug specifically developed for this condition. Continued pipeline development, including Lipocine's LPCN 1154 which may become the fastest-acting oral therapy for postpartum depression, continues pushing this disease indication category's growth rate ahead of the broader disease indication segmentation.

By Treatment, interpersonal psychotherapy segment dominates the market and grows fastest

The interpersonal psychotherapy segment held approximately 40.00% of total market revenue in 2025, and is also projected to grow at the fastest CAGR through the forecast period, considered an effective therapy for treating a variety of maternal mental health conditions due to its growing usage, especially for postpartum depression. That dual leadership and continued growth trajectory reflects how comprehensively interpersonal psychotherapy continues capturing clinician and patient preference relative to the broader treatment segmentation, with antidepressants and other pharmacotherapy continuing to represent a substantial complementary treatment category.

By End-User, hospitals and clinics segment dominates the market, telehealth digital platforms grows fastest

The hospitals and clinics segment held the largest share of the end-user segmentation in 2025, anchored by the clinical infrastructure required for comprehensive perinatal mental health screening, diagnosis, and treatment across obstetric and psychiatric care settings. That established clinical infrastructure continues to keep hospitals and clinics firmly at the top of the broader end-user segmentation across nearly every major regional healthcare market worldwide.

The telehealth digital platforms segment is projected to grow at the fastest CAGR during the forecast period, as growing incorporation of technology in healthcare services continues resulting in significant commercial advances that expand access to maternal mental health support beyond traditional clinical settings. Rising adoption of digital mental health platforms continues pushing this end-user category's growth rate ahead of the broader end-user segmentation.

Regional Analysis

North America Maternal Mental Health Market Insights

North America dominated the global maternal mental health market in 2025, driven by high demand for perinatal depression screening, rising mental health issues, and government-backed mental health programs across the region. The Enhancing Maternal Health Initiative and other federally-funded programs continued reinforcing this leadership position throughout the year.

The US held an estimated share of 85.20% in the revenue share of the region, given that it is home to many major maternal mental health platform developers along with a robust government funding structure. Canada was responsible for the smaller, yet increasing share of revenue in the region, owing to its growing investments in the maternal mental health program.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Maternal Mental Health Market Insights

Europe held a substantial share of the global maternal mental health market in 2025, supported by the European Framework for Action on Mental Health, which provides a basis to mainstream, promote, and safeguard mental well-being while promoting investment in accessible quality mental health services. Germany accounted for roughly 27.10% of regional revenue, supported by its concentration of mental health technology companies and comprehensive national health insurance coverage.

The United Kingdom, France, and the Nordic countries followed a broadly similar trajectory, as continued digitization for the prevention and management of mental health conditions extended maternal mental health demand across the continent's largest healthcare markets. Continued regulatory support for accessible mental health services is expected to keep supporting steady European demand through the remainder of the forecast period.

Asia Pacific Maternal Mental Health Market Insights

Asia Pacific was the fastest-growing region in the global maternal mental health market, supported by expanding government-backed maternal and child health programs, including China's five-year Action Plan for Maternal and Child Health Improvement, across the region's largest and most populous economies. Rising healthcare investment and mental health awareness continued driving regional demand at a pace considerably faster than more mature Western markets.

China constituted around 36.20% of the regional revenue due to continued investments made by the government towards the safety systems in the maternal and child healthcare sector. India and Japan also played a big role in providing regional demand due to their growing maternal healthcare systems.

MEA & Latin America Maternal Mental Health Market Insights

In 2025, there was consistency in the growth of maternal mental health adoption in the Middle East & Africa region, which was spurred by the growth of investment in infrastructure that provides maternal healthcare, as well as increasing support from the government on the provision of perinatal mental health screening programs in the Gulf countries. Approximately 26.20% of revenues were generated from the UAE.

Latin America expanded at a comparable pace, led by Brazil at roughly 37.00% of regional revenue, where growing maternal healthcare infrastructure investment continued to support category growth. Mexico and Argentina followed a similar trajectory as regional maternal mental health awareness expanded further through the remainder of the forecast period.

Market Dynamics

Growth Drivers: Rising Postpartum Depression Awareness and Government Funding Expansion

Increasing funding from governments to lower rates of maternal mortality, rising rates of postpartum depression, and growing awareness programs focused on mental well-being before and during pregnancy continue to be the central force behind maternal mental health market growth. With forty percent of women experiencing symptoms of maternal mental disorders after childbirth, demand for effective mental well-being management continues reinforcing structural demand growth across nearly every major regional healthcare market worldwide.

The rising awareness and recognition of perinatal mental health disorders, combined with a reduction in social stigma, continues driving sustained market expansion. Significant progress in AI-based identification of perinatal mental health conditions, alongside pharmaceutical innovation including oral postpartum depression drugs, continues reinforcing sustained market growth through the forecast period.

Restraints: Treatment Access Gaps and Stigma-Related Underdiagnosis

The continued underdiagnosis of maternal mental illnesses due to the stigmatization associated with mental illnesses related to the perinatal period is limiting the size of the treatable patient population. This issue will continue to require continued efforts to raise awareness and educate clinicians.

Limited access to specialized perinatal mental health providers, particularly in rural and underserved regions, continues restricting timely treatment initiation for affected mothers. That access limitation continues requiring expansion of telehealth and digital platform capacity to reach patients lacking convenient access to in-person specialized care.

Opportunities: AI-Driven Screening Technology and Novel Pharmacotherapy Pipeline Expansion

Continued advancement of AI-driven screening and diagnostic tools presents substantial opportunity for companies positioned to improve early identification of perinatal mental health conditions before symptoms become severe. Companies capable of delivering clinically validated, accessible screening technology stand to capture a growing share of demand as this technology continues maturing.

The ongoing development of the pipeline for such pharmaceuticals, including rapid-acting oral medications for postpartum depression, offers another promising avenue for growth, as companies strive to develop treatments that offer faster relief from symptoms compared to conventional antidepressants. Such companies will be able to derive substantial profits through 2035.

Recent Developments:

• 2025: The UK's National Institute for Health and Care Research funded CHIME in March, a significant global health research program using music to help pregnant women's mental health, representing an investment of over 2.8 million pounds in maternal mental health research in the Global South.
• 2025: Brightside Health continued expanding its digital maternal mental health platform, strengthening its position serving patients seeking accessible, technology-enabled psychiatric care during pregnancy and postpartum.
• 2025: Sage Therapeutics continued advancing its postpartum depression treatment portfolio, building on the foundational FDA approval of zuranolone as the first oral, fast-acting therapy for this condition.

Maternal Mental Health Market key players are:

• Maven Clinic
• Wildflower Health
• Hims & Hers Health, Inc.
• Medela LLC
• Clue
• Postpartum Support International
• LunaJoy Health
• Brightside Health, Inc.
• Viatris Inc.
• GSK plc
• Alembic Pharmaceuticals Limited
• Mallinckrodt plc
• Sage Therapeutics, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.
• Pfizer Inc.
• Eli Lilly and Company
• Lipocine Inc.
• Canopie
• Seleni Institute

Maternal Mental Health Market Report Scope :